Skip to content

Nasal spray in sinusitis and cold

To study the efficacy of Kalingadi Arka nasal spray in Kaphaja prathishyaya( Chronic rhinosinusitis) An open labelled randomized controlled clinical study - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070306
Enrollment
40
Registered
2024-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J310- Chronic rhinitis

Interventions

None listed

Sponsors

Dr VIDYA R E
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with clinical features of Kaphaja Prathishyaya (chronic rhinosinusitis) 2.Subjects fit for Nasya karma 3.Patient of either sex, with age group between 20-40 years 4.Patients with chronicity less than 5year

Exclusion criteria

Exclusion criteria: 1. Patients with any other systemic disorders (like TB, HIV, Retro positive diabetes, Hypertension and Thyroid.) that may interfere the course of treatment 2. Any associated conditions like migraine headache, referred pain from dental pathology will be excluded 3. Patients with nasal polyps along with rhinosinusitis will not be considered for the study 4. Patients suffering from Chronic Simple Rhinitis associated with tonsillitis, adenoids 5. Patients of gross DNS being the reason for nasal blockage

Design outcomes

Primary

MeasureTime frame
1.Nasa srava (Nasal discharge) 2.Pratisthabdam (Nasal obstruction) 3.Gala, Oshta, Talu kanduyana (Itching throat, palate and lips) 4.Mukhashiro guruthva (Heaviness of Face and Head) 5.Aruchi (Anorexia) 6.Nasanaha (Oedema of the middle meatus) 7.Shirashoola (Headache) Timepoint: 15 DAYS

Secondary

MeasureTime frame
1.Sustained effect of treatment on Subjective Parameters 2.Improvement changes in SNOT-22 questionnaire. 3.To develop easily approachable cost-effective treatment Timepoint: 15 DAYS;1.Sustained effect of treatment on Subjective Parameters 2.Improvement changes in SNOT-22 questionnaire. 3.To develop easily approachable cost-effective treatment Timepoint: 15 DAYS

Countries

India

Contacts

Public ContactDr Mamatha K V

SDM institute of Ayurveda and Hospital

mail2mamatha@sdmayurbangalore.in76191659348

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026